AIP
RDY icon

Almanack Investment Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Almanack Investment Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,500
Closed -$309K – 447
2020
Q3 		$309K Hold
24,500
– – 0.04% 291
2020
Q2 		$260K Buy
+24,500
New +$249K 0.05% 205

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Almanack Investment Partners's RDY Position: Q4 2020 in Review

Almanack Investment Partners sold out of Dr. Reddy's Laboratories (RDY) in Q4 2020, closing a stake of 24,500 shares — an estimated $309K sold.

Almanack Investment Partners first reported a position in RDY in Q2 2020 and held it in 2 quarters. The position peaked at $309K in Q3 2020. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2020.

  • Almanack Investment Partners reported no remaining Dr. Reddy's Laboratories position as of Q4 2020 after selling out during the quarter.
  • Almanack Investment Partners sold 24,500 Dr. Reddy's Laboratories shares in Q4 2020, an estimated $309K.
  • Almanack Investment Partners first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 2 quarters.
  • Almanack Investment Partners's Dr. Reddy's Laboratories position peaked at $309K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2020.

Based on Almanack Investment Partners's 13F filing for Q4 2020, filed 3 Feb 2021.